PCM
LMAT icon

Prelude Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Prelude Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,472
Closed -$323K – 1396
2024
Q3 		$323K Sell
3,472
-272
-7% -$23.6K 0.02% 829
2024
Q2 		$308K Sell
3,744
-1,291
-26% -$94.8K 0.02% 778
2024
Q1 		$334K Buy
+5,035
New +$311K 0.02% 843
2019
Q2 		– Sell
-284
Closed -$9K – 1928
2019
Q1 		$9K Buy
+284
New +$7.58K ﹤0.01% 1470
2018
Q3 		– Sell
-100
Closed -$3K – 1897
2018
Q2 		$3K Buy
+100
New +$3.56K ﹤0.01% 1587
2017
Q1 		– Sell
-9,600
Closed -$243K – 1643
2016
Q4 		$243K Buy
9,600
+700
+8% +$15.5K 0.03% 506
2016
Q3 		$177K Sell
8,900
-1,000
-10% -$17.5K 0.02% 603
2016
Q2 		$141K Sell
9,900
-5,000
-34% -$76.4K 0.02% 617
2016
Q1 		$231K Buy
14,900
+2,700
+22% +$38.7K 0.03% 505
2015
Q4 		$210K Buy
12,200
+6,980
+134% +$101K 0.03% 540
2015
Q3 		$64K Sell
5,220
-2,800
-35% -$35.9K 0.01% 978
2015
Q2 		$97K Buy
+8,020
New +$78.9K 0.01% 895

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's LMAT Position: Q4 2024 in Review

Prelude Capital Management sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 3,472 shares — an estimated $323K sold.

Prelude Capital Management first reported a position in LMAT in Q2 2015 and held it in 12 quarters. The position peaked at $334K in Q1 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Prelude Capital Management reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Prelude Capital Management sold 3,472 LeMaitre Vascular shares in Q4 2024, an estimated $323K.
  • Prelude Capital Management first reported a position in LeMaitre Vascular in Q2 2015 and held it in 12 quarters.
  • Prelude Capital Management's LeMaitre Vascular position peaked at $334K in Q1 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.